Academic Journal
Multicenter Evaluation of Large Language Models Versus Hepatologists for Prognostic Prediction in Drug-Induced Liver Injury.
| Τίτλος: | Multicenter Evaluation of Large Language Models Versus Hepatologists for Prognostic Prediction in Drug-Induced Liver Injury. |
|---|---|
| Συγγραφείς: | Fu H; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Du Y; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhao G; Department of Infectious Diseases, Ruijin North Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Xiao Y; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Song S; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zang X; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhou T; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Zhuang Y; Department of Infectious Diseases, Wuxi Xinrui Hospital, Shanghai Jiao Tong University School of Medicine, Wuxi, China., Mo R; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Lai R; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Xie Q; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. |
| Πηγή: | Liver international : official journal of the International Association for the Study of the Liver [Liver Int] 2026 Oct; Vol. 46 (10), pp. e70879. |
| Τύπος έκδοσης: | Journal Article; Multicenter Study; Comparative Study |
| Γλώσσα: | English |
| Στοιχεία περιοδικού: | Publisher: Wiley-Blackwell Country of Publication: United States NLM ID: 101160857 Publication Model: Print Cited Medium: Internet ISSN: 1478-3231 (Electronic) Linking ISSN: 14783223 NLM ISO Abbreviation: Liver Int Subsets: MEDLINE |
| Imprint Name(s): | Publication: Malden, MA : Wiley-Blackwell Original Publication: Oxford, UK : Blackwell Munksgaard, c2003- |
| Ιατρικοί όροι (MeSH): | Chemical and Drug Induced Liver Injury*/diagnosis , Chemical and Drug Induced Liver Injury*/mortality , Large Language Models* , Gastroenterology*, Humans ; Prognosis ; Male ; Female ; Middle Aged ; ROC Curve ; Clinical Decision-Making |
| Περίληψη: | Background & Aims: Drug-induced liver injury (DILI) would progress to chronicity or death. Large language models (LLMs) may enhance clinical decision-making, yet their utility relative to physicians in DILI remains unclear. Therefore, we evaluated their performance in predicting DILI outcomes. Methods: We enrolled 943 DILI patients from three centers as internal and external cohorts. Based on 12-month follow-up, outcomes were classified as recovery, 6/12-month chronicity, and death. LLMs (Gemini-2.5 Pro, GPT-5.1, DeepSeek-3.2), hepatologists (Junior, middle, senior), and models (Hy's Law, nHy's Law, MELD Score) estimated probabilities of outcomes. LLM-Rules (VOTE, OR, AND) were applied to enhance stability. Model performance was assessed. Results: For 6-month chronicity, the senior achieved highest AUROC (0.61) with an accuracy of 70%. Gemini-2.5 Pro and GPT-5.1 yielded AUROCs of 0.60 and 0.59, respectively, outperforming junior and middle hepatologists. Gemini-2.5 Pro demonstrated strongest agreement with senior (κ = 0.43). LLMs all exhibited lower accuracy and specificity than hepatologists. A similar result was observed in 12-month chronicity. For overall mortality, the senior achieved highest AUROC (0.87) with an accuracy of 83%. Gemini-2.5 Pro and GPT-5.1 achieved AUROCs of 0.86, outperforming junior hepatologist, Hy's Law, and nHy's Law. GPT-5.1 achieved strongest agreement with senior (κ = 0.25). LLM-Rules demonstrated stability for predicting outcomes across cohorts. OR and AND rules improved sensitivity and specificity, respectively. Conclusions: GPT-5.1 and Gemini-2.5 Pro showed AUROCs approaching senior hepatologists for DILI outcomes with limited accuracy and specificity. LLM-Rules demonstrated stable performance across cohorts with improved sensitivity or specificity, supporting the potential of multi-LLM approaches as clinician-supervised complementary tools. (© 2026 The Author(s). Liver International published by John Wiley & Sons Ltd.) |
| References: | Perspect Biol Med. 1968 Autumn;12(1):135-61. (PMID: 4387099) J Med Syst. 2025 May 15;49(1):64. (PMID: 40372503) JHEP Rep. 2025 Sep 03;7(12):101579. (PMID: 41321931) Clin Mol Hepatol. 2023 Jul;29(3):721-732. (PMID: 36946005) Hepatology. 2010 Dec;52(6):2065-76. (PMID: 20949552) J Hepatol. 2016 Sep;65(3):532-42. (PMID: 27184533) Gastroenterology. 2019 Nov;157(5):1245-1252.e3. (PMID: 31302142) Liver Int. 2019 Jan;39(1):31-41. (PMID: 30003672) Hepatology. 2000 Apr;31(4):864-71. (PMID: 10733541) Front Immunol. 2022 Apr 12;13:772368. (PMID: 35493499) Liver Int. 2025 Apr;45(4):e16112. (PMID: 39526465) Clin Gastroenterol Hepatol. 2015 Dec;13(13):2360-8. (PMID: 26122767) Nature. 2015 May 28;521(7553):452-9. (PMID: 26017444) J Med Internet Res. 2024 May 22;26:e53164. (PMID: 38776130) Nat Med. 2025 Jan;31(1):60-69. (PMID: 39779929) Liver Int. 2026 Oct;46(10):e70879. (PMID: 42757445) J Hepatol. 1990 Sep;11(2):272-6. (PMID: 2254635) Hepatology. 2017 Oct;66(4):1275-1285. (PMID: 28543844) Gastroenterology. 2015 Jun;148(7):1340-52.e7. (PMID: 25754159) Hepatol Commun. 2020 Feb 20;4(4):518-526. (PMID: 32258947) Liver Int. 2018 Jan;38(1):6-14. (PMID: 28771932) J Hepatol. 2023 Mar;78(3):663-671. (PMID: 36283499) Liver Int. 2025 Jun;45(6):e70115. (PMID: 40347005) J Hepatol. 2019 Jun;70(6):1222-1261. (PMID: 30926241) Gastroenterology. 2014 Jul;147(1):109-118.e5. (PMID: 24704526) Clin Pharmacol Ther. 2011 Jun;89(6):806-15. (PMID: 21544079) J Hepatol. 2022 Aug;77(2):293-295. (PMID: 35421424) Hepatol Int. 2023 Dec;17(6):1626-1636. (PMID: 37188998) Hepatol Res. 2020 Feb;50(2):224-232. (PMID: 31652370) Scand J Gastroenterol. 2015 Apr;50(4):439-46. (PMID: 25639449) Hepatol Int. 2023 Apr;17(2):488-498. (PMID: 36327052) JAMA Netw Open. 2023 Oct 2;6(10):e2336483. (PMID: 37782499) |
| Grant Information: | 82270618 National Natural Science Foundation of China; 2025ZD01906200 Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project |
| Contributed Indexing: | Keywords: chemical and drug induced liver injury; chronic disease; clinical outcome; large language models; liver failure; prognosis Local Abstract: [plain-language-summary] Drug‐induced liver injury (DILI) would progress to chronicity or death. We evaluate the utility of large language models (LLMs) in predicting DILI outcomes. We found GPT‐5.1 and Gemini‐2.5 Pro showed AUROCs approaching senior hepatologists for DILI outcomes with limited accuracy and specificity. LLM‐Rules demonstrated stable performance across cohorts with improved sensitivity or specificity, supporting the potential of multi‐LLM approaches as clinician‐supervised complementary tools. |
| Entry Date(s): | Date Created: 20260918 Date Completed: 20260918 Latest Revision: 20261005 |
| Update Code: | 20261005 |
| PubMed Central ID: | PMC13586842 |
| DOI: | 10.1111/liv.70879 |
| PMID: | 42757445 |
| Βάση Δεδομένων: | MEDLINE |
| FullText | Text: Availability: 0 CustomLinks: – Url: https://resolver.ebsco.com/c/fiv2js/result?sid=EBSCO:cmedm&genre=article&issn=14783231&ISBN=&volume=46&issue=10&date=20261001&spage=e70879&pages=e70879&title=Liver international : official journal of the International Association for the Study of the Liver&atitle=Multicenter%20Evaluation%20of%20Large%20Language%20Models%20Versus%20Hepatologists%20for%20Prognostic%20Prediction%20in%20Drug-Induced%20Liver%20Injury.&aulast=Fu%20H&id=DOI:10.1111/liv.70879 Name: Full Text Finder (for New FTF UI) (ns324271) Category: fullText Text: Full Text Finder MouseOverText: Full Text Finder |
|---|---|
| Header | DbId: cmedm DbLabel: MEDLINE An: 42757445 AccessLevel: 3 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Multicenter Evaluation of Large Language Models Versus Hepatologists for Prognostic Prediction in Drug-Induced Liver Injury. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Fu+H%22">Fu H</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Du+Y%22">Du Y</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhao+G%22">Zhao G</searchLink>; Department of Infectious Diseases, Ruijin North Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xiao+Y%22">Xiao Y</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Song+S%22">Song S</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zang+X%22">Zang X</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhou+T%22">Zhou T</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Zhuang+Y%22">Zhuang Y</searchLink>; Department of Infectious Diseases, Wuxi Xinrui Hospital, Shanghai Jiao Tong University School of Medicine, Wuxi, China.<br /><searchLink fieldCode="AU" term="%22Mo+R%22">Mo R</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Lai+R%22">Lai R</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.<br /><searchLink fieldCode="AU" term="%22Xie+Q%22">Xie Q</searchLink>; Department of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101160857%22">Liver international : official journal of the International Association for the Study of the Liver</searchLink> [Liver Int] 2026 Oct; Vol. 46 (10), pp. e70879. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Multicenter Study; Comparative Study – Name: Language Label: Language Group: Lang Data: English – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley-Blackwell%22">Wiley-Blackwell </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101160857 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1478-3231 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214783223%22">14783223 </searchLink><i>NLM ISO Abbreviation: </i>Liver Int <i>Subsets: </i>MEDLINE – Name: PublisherInfo Label: Imprint Name(s) Group: PubInfo Data: <i>Publication</i>: Malden, MA : Wiley-Blackwell<br /><i>Original Publication</i>: Oxford, UK : Blackwell Munksgaard, c2003- – Name: SubjectMESH Label: MeSH Terms Group: Su Data: <searchLink fieldCode="MM" term="%22Chemical+and+Drug+Induced+Liver+Injury%22">Chemical and Drug Induced Liver Injury*</searchLink>/<searchLink fieldCode="MM" term="%22Chemical+and+Drug+Induced+Liver+Injury+diagnosis%22">diagnosis</searchLink> <br /><searchLink fieldCode="MM" term="%22Chemical+and+Drug+Induced+Liver+Injury%22">Chemical and Drug Induced Liver Injury*</searchLink>/<searchLink fieldCode="MM" term="%22Chemical+and+Drug+Induced+Liver+Injury+mortality%22">mortality</searchLink> <br /><searchLink fieldCode="MM" term="%22Large+Language+Models%22">Large Language Models*</searchLink> <br /><searchLink fieldCode="MM" term="%22Gastroenterology%22">Gastroenterology*</searchLink><br /><searchLink fieldCode="MH" term="%22Humans%22">Humans</searchLink> ; <searchLink fieldCode="MH" term="%22Prognosis%22">Prognosis</searchLink> ; <searchLink fieldCode="MH" term="%22Male%22">Male</searchLink> ; <searchLink fieldCode="MH" term="%22Female%22">Female</searchLink> ; <searchLink fieldCode="MH" term="%22Middle+Aged%22">Middle Aged</searchLink> ; <searchLink fieldCode="MH" term="%22ROC+Curve%22">ROC Curve</searchLink> ; <searchLink fieldCode="MH" term="%22Clinical+Decision-Making%22">Clinical Decision-Making</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Background & Aims: Drug-induced liver injury (DILI) would progress to chronicity or death. Large language models (LLMs) may enhance clinical decision-making, yet their utility relative to physicians in DILI remains unclear. Therefore, we evaluated their performance in predicting DILI outcomes.<br />Methods: We enrolled 943 DILI patients from three centers as internal and external cohorts. Based on 12-month follow-up, outcomes were classified as recovery, 6/12-month chronicity, and death. LLMs (Gemini-2.5 Pro, GPT-5.1, DeepSeek-3.2), hepatologists (Junior, middle, senior), and models (Hy's Law, nHy's Law, MELD Score) estimated probabilities of outcomes. LLM-Rules (VOTE, OR, AND) were applied to enhance stability. Model performance was assessed.<br />Results: For 6-month chronicity, the senior achieved highest AUROC (0.61) with an accuracy of 70%. Gemini-2.5 Pro and GPT-5.1 yielded AUROCs of 0.60 and 0.59, respectively, outperforming junior and middle hepatologists. Gemini-2.5 Pro demonstrated strongest agreement with senior (κ = 0.43). LLMs all exhibited lower accuracy and specificity than hepatologists. A similar result was observed in 12-month chronicity. For overall mortality, the senior achieved highest AUROC (0.87) with an accuracy of 83%. Gemini-2.5 Pro and GPT-5.1 achieved AUROCs of 0.86, outperforming junior hepatologist, Hy's Law, and nHy's Law. GPT-5.1 achieved strongest agreement with senior (κ = 0.25). LLM-Rules demonstrated stability for predicting outcomes across cohorts. OR and AND rules improved sensitivity and specificity, respectively.<br />Conclusions: GPT-5.1 and Gemini-2.5 Pro showed AUROCs approaching senior hepatologists for DILI outcomes with limited accuracy and specificity. LLM-Rules demonstrated stable performance across cohorts with improved sensitivity or specificity, supporting the potential of multi-LLM approaches as clinician-supervised complementary tools.<br /> (© 2026 The Author(s). Liver International published by John Wiley & Sons Ltd.) – Name: Ref Label: References Group: RefInfo Data: Perspect Biol Med. 1968 Autumn;12(1):135-61. (PMID: <searchLink fieldCode="PM" term="%224387099%22">4387099)</searchLink><br />J Med Syst. 2025 May 15;49(1):64. (PMID: <searchLink fieldCode="PM" term="%2240372503%22">40372503)</searchLink><br />JHEP Rep. 2025 Sep 03;7(12):101579. (PMID: <searchLink fieldCode="PM" term="%2241321931%22">41321931)</searchLink><br />Clin Mol Hepatol. 2023 Jul;29(3):721-732. (PMID: <searchLink fieldCode="PM" term="%2236946005%22">36946005)</searchLink><br />Hepatology. 2010 Dec;52(6):2065-76. (PMID: <searchLink fieldCode="PM" term="%2220949552%22">20949552)</searchLink><br />J Hepatol. 2016 Sep;65(3):532-42. (PMID: <searchLink fieldCode="PM" term="%2227184533%22">27184533)</searchLink><br />Gastroenterology. 2019 Nov;157(5):1245-1252.e3. (PMID: <searchLink fieldCode="PM" term="%2231302142%22">31302142)</searchLink><br />Liver Int. 2019 Jan;39(1):31-41. (PMID: <searchLink fieldCode="PM" term="%2230003672%22">30003672)</searchLink><br />Hepatology. 2000 Apr;31(4):864-71. (PMID: <searchLink fieldCode="PM" term="%2210733541%22">10733541)</searchLink><br />Front Immunol. 2022 Apr 12;13:772368. (PMID: <searchLink fieldCode="PM" term="%2235493499%22">35493499)</searchLink><br />Liver Int. 2025 Apr;45(4):e16112. (PMID: <searchLink fieldCode="PM" term="%2239526465%22">39526465)</searchLink><br />Clin Gastroenterol Hepatol. 2015 Dec;13(13):2360-8. (PMID: <searchLink fieldCode="PM" term="%2226122767%22">26122767)</searchLink><br />Nature. 2015 May 28;521(7553):452-9. (PMID: <searchLink fieldCode="PM" term="%2226017444%22">26017444)</searchLink><br />J Med Internet Res. 2024 May 22;26:e53164. (PMID: <searchLink fieldCode="PM" term="%2238776130%22">38776130)</searchLink><br />Nat Med. 2025 Jan;31(1):60-69. (PMID: <searchLink fieldCode="PM" term="%2239779929%22">39779929)</searchLink><br />Liver Int. 2026 Oct;46(10):e70879. (PMID: <searchLink fieldCode="PM" term="%2242757445%22">42757445)</searchLink><br />J Hepatol. 1990 Sep;11(2):272-6. (PMID: <searchLink fieldCode="PM" term="%222254635%22">2254635)</searchLink><br />Hepatology. 2017 Oct;66(4):1275-1285. (PMID: <searchLink fieldCode="PM" term="%2228543844%22">28543844)</searchLink><br />Gastroenterology. 2015 Jun;148(7):1340-52.e7. (PMID: <searchLink fieldCode="PM" term="%2225754159%22">25754159)</searchLink><br />Hepatol Commun. 2020 Feb 20;4(4):518-526. (PMID: <searchLink fieldCode="PM" term="%2232258947%22">32258947)</searchLink><br />Liver Int. 2018 Jan;38(1):6-14. (PMID: <searchLink fieldCode="PM" term="%2228771932%22">28771932)</searchLink><br />J Hepatol. 2023 Mar;78(3):663-671. (PMID: <searchLink fieldCode="PM" term="%2236283499%22">36283499)</searchLink><br />Liver Int. 2025 Jun;45(6):e70115. (PMID: <searchLink fieldCode="PM" term="%2240347005%22">40347005)</searchLink><br />J Hepatol. 2019 Jun;70(6):1222-1261. (PMID: <searchLink fieldCode="PM" term="%2230926241%22">30926241)</searchLink><br />Gastroenterology. 2014 Jul;147(1):109-118.e5. (PMID: <searchLink fieldCode="PM" term="%2224704526%22">24704526)</searchLink><br />Clin Pharmacol Ther. 2011 Jun;89(6):806-15. (PMID: <searchLink fieldCode="PM" term="%2221544079%22">21544079)</searchLink><br />J Hepatol. 2022 Aug;77(2):293-295. (PMID: <searchLink fieldCode="PM" term="%2235421424%22">35421424)</searchLink><br />Hepatol Int. 2023 Dec;17(6):1626-1636. (PMID: <searchLink fieldCode="PM" term="%2237188998%22">37188998)</searchLink><br />Hepatol Res. 2020 Feb;50(2):224-232. (PMID: <searchLink fieldCode="PM" term="%2231652370%22">31652370)</searchLink><br />Scand J Gastroenterol. 2015 Apr;50(4):439-46. (PMID: <searchLink fieldCode="PM" term="%2225639449%22">25639449)</searchLink><br />Hepatol Int. 2023 Apr;17(2):488-498. (PMID: <searchLink fieldCode="PM" term="%2236327052%22">36327052)</searchLink><br />JAMA Netw Open. 2023 Oct 2;6(10):e2336483. (PMID: <searchLink fieldCode="PM" term="%2237782499%22">37782499)</searchLink> – Name: GrantInfo Label: Grant Information Group: Grant Data: 82270618 National Natural Science Foundation of China; 2025ZD01906200 Prevention and Control of Emerging and Major Infectious Diseases-National Science and Technology Major Project – Name: SubjectMinor Label: Contributed Indexing Group: Data: <i>Keywords: </i>chemical and drug induced liver injury; chronic disease; clinical outcome; large language models; liver failure; prognosis<br /><i>Local Abstract: </i>[plain-language-summary] Drug‐induced liver injury (DILI) would progress to chronicity or death. We evaluate the utility of large language models (LLMs) in predicting DILI outcomes. We found GPT‐5.1 and Gemini‐2.5 Pro showed AUROCs approaching senior hepatologists for DILI outcomes with limited accuracy and specificity. LLM‐Rules demonstrated stable performance across cohorts with improved sensitivity or specificity, supporting the potential of multi‐LLM approaches as clinician‐supervised complementary tools. – Name: DateEntry Label: Entry Date(s) Group: Date Data: <i>Date Created: </i>20260918 <i>Date Completed: </i>20260918 <i>Latest Revision: </i>20261005 – Name: DateUpdate Label: Update Code Group: Date Data: 20261005 – Name: PubmedCentralID Label: PubMed Central ID Group: ID Data: PMC13586842 – Name: DOI Label: DOI Group: ID Data: 10.1111/liv.70879 – Name: AN Label: PMID Group: ID Data: 42757445 |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=cmedm&AN=42757445 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1111/liv.70879 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70879 Subjects: – SubjectFull: Humans Type: general – SubjectFull: Prognosis Type: general – SubjectFull: Male Type: general – SubjectFull: Female Type: general – SubjectFull: Middle Aged Type: general – SubjectFull: ROC Curve Type: general – SubjectFull: Clinical Decision-Making Type: general – SubjectFull: Chemical and Drug Induced Liver Injury diagnosis Type: general – SubjectFull: Chemical and Drug Induced Liver Injury mortality Type: general – SubjectFull: Large Language Models Type: general – SubjectFull: Gastroenterology Type: general Titles: – TitleFull: Multicenter Evaluation of Large Language Models Versus Hepatologists for Prognostic Prediction in Drug-Induced Liver Injury. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Fu H – PersonEntity: Name: NameFull: Du Y – PersonEntity: Name: NameFull: Zhao G – PersonEntity: Name: NameFull: Xiao Y – PersonEntity: Name: NameFull: Song S – PersonEntity: Name: NameFull: Zang X – PersonEntity: Name: NameFull: Zhou T – PersonEntity: Name: NameFull: Zhuang Y – PersonEntity: Name: NameFull: Mo R – PersonEntity: Name: NameFull: Lai R – PersonEntity: Name: NameFull: Xie Q IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 10 Text: 2026 Oct Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1478-3231 Numbering: – Type: volume Value: 46 – Type: issue Value: 10 Titles: – TitleFull: Liver international : official journal of the International Association for the Study of the Liver Type: main |
| ResultId | 1 |